Stephan Stilgenbauer Selected Research

Cell Transplantation

1/2022	Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study.
1/2021	Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study.
12/2016	Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Stilgenbauer Research Topics

Disease

172	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024 - 08/2002
53	Neoplasms (Cancer) 04/2024 - 01/2003
24	Disease Progression 10/2023 - 08/2004
21	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2024 - 10/2003
19	Lymphoma (Lymphomas) 12/2023 - 11/2006
18	Infections 05/2024 - 06/2013
16	Residual Neoplasm 12/2023 - 10/2004
12	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 09/2015
11	Leukemia 01/2022 - 10/2004
8	Neutropenia 01/2020 - 03/2014
7	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 01/2004
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2022 - 08/2013
7	Lymphadenopathy 11/2019 - 08/2004
5	COVID-19 01/2022 - 01/2020
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 08/2010
5	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 09/2015
4	Hemorrhage 01/2023 - 08/2015
4	Diarrhea 01/2023 - 08/2015
4	Pneumonia (Pneumonitis) 01/2022 - 01/2017
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2015
4	Carcinogenesis 10/2015 - 11/2008
3	Genomic Instability 09/2023 - 06/2016
3	Atrial Fibrillation 01/2023 - 11/2021
3	T-Cell Leukemia (Leukemia, T Cell) 01/2023 - 06/2013
3	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 06/2013
3	Inflammation (Inflammations) 01/2021 - 10/2017
3	Febrile Neutropenia 01/2021 - 08/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2020 - 01/2015
2	Tumor Lysis Syndrome 02/2024 - 11/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 04/2006
2	Cough 01/2023 - 12/2018
2	Hypertension (High Blood Pressure) 01/2023 - 02/2006
2	Multiple Myeloma 01/2021 - 07/2003
2	Sepsis (Septicemia) 01/2021 - 01/2020
2	Trisomy (Trisomies) 01/2020 - 01/2004
2	Fever (Fevers) 12/2018 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 04/2013
2	Anemia 12/2018 - 02/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 12/2015

Drug/Important Bio-Agent (IBA)

38	Rituximab (Mabthera)FDA Link 05/2024 - 01/2010
29	fludarabineIBA 05/2024 - 08/2004
29	venetoclaxIBA 02/2024 - 06/2016
28	ibrutinibIBA 05/2024 - 08/2013
24	obinutuzumabIBA 04/2024 - 03/2014
22	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 02/2006
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2006
13	Bendamustine Hydrochloride FDA Link 04/2024 - 09/2011
13	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 08/2013
11	idelalisibIBA 04/2024 - 03/2014
11	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 08/2002
10	ofatumumab FDA Link 01/2021 - 04/2010
9	Chlorambucil (Leukeran)FDA Link 10/2023 - 10/2009
7	Lenalidomide (CC 5013)FDA Link 01/2021 - 12/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2004
6	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2008
6	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022 - 02/2006
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2008
6	Alemtuzumab (Campath)FDA Link 03/2017 - 09/2006
5	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 05/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023 - 08/2016
5	AutoantigensIBA 10/2021 - 12/2018
4	Vincristine (Oncovin)FDA LinkGeneric 07/2023 - 08/2016
4	AntibodiesIBA 05/2023 - 01/2018
4	Prednisone (Sone)FDA LinkGeneric 02/2022 - 08/2016
4	Transcription Factors (Transcription Factor)IBA 11/2021 - 09/2015
4	EpitopesIBA 08/2021 - 10/2009
3	duvelisibIBA 03/2023 - 12/2018
3	serum P-component (CIt)IBA 01/2023 - 01/2018
3	acalabrutinibIBA 01/2023 - 01/2021
3	AntigensIBA 01/2021 - 01/2010
3	Thymidine KinaseIBA 01/2020 - 01/2017
3	neurabinIBA 01/2020 - 12/2018
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2004
3	CytokinesIBA 01/2018 - 03/2011
3	Methotrexate (Mexate)FDA LinkGeneric 11/2017 - 05/2016
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2017 - 05/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 08/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2023 - 08/2010
2	LigandsIBA 12/2022 - 04/2006
2	tirabrutinibIBA 06/2022 - 04/2022
2	Immunoglobulin G (IgG)IBA 01/2022 - 08/2021
2	Interleukin-10 (Interleukin 10)IBA 12/2021 - 01/2021
2	Interleukin-10 ReceptorsIBA 12/2021 - 01/2021
2	Interferon-alpha (Interferon Alfa)IBA 09/2021 - 01/2020
2	ExotoxinsIBA 01/2020 - 12/2018
2	ProgranulinsIBA 06/2019 - 01/2013
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 12/2018
2	Phospholipases (Phospholipase)IBA 09/2018 - 10/2016
2	RNA (Ribonucleic Acid)IBA 11/2016 - 09/2015
2	CreatinineIBA 08/2016 - 02/2006

Therapy/Procedure

55	Therapeutics 04/2024 - 04/2004
25	Drug Therapy (Chemotherapy) 12/2023 - 08/2002
17	Stem Cell Transplantation 05/2024 - 03/2003
5	Transplantation 01/2019 - 11/2008
4	Radiotherapy 07/2023 - 05/2016
4	Immunotherapy 12/2021 - 04/2010
4	Hematopoietic Stem Cell Transplantation 01/2020 - 11/2008
3	Cell Transplantation 01/2022 - 12/2016
2	Salvage Therapy 01/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2018 - 01/2016